Chikungunya virus (CHIKV) is a mosquito-borne virus belonging to the Togaviridae family, specifically the Alphavirus genus, a group of enveloped, single-stranded RNA viruses that cause severe diseases in humans and animals. CHIKV has been reported in 119 countries and regions, and there is a potential for widespread outbreak. On July 22, the WHO issued an alert on potential large-scale outbreaks of chikungunya, reminding countries to prepare for solutions to avoid large-scale outbreak.
In response to the current CHIKV mutant outbreak, Sino Biological quickly launched recombinant E1 and E2 proteins, as well as antibodies, to support researchers in the development of vaccines, antiviral drugs, and immunodiagnostic assays.
Click here to learn more about chikungunya virus
